Related Experiment Video
Updated: Jul 6, 2026

07:45
"Sun's Seven-Step Technique" for Endoscopic En-Bloc Resection of Thyroid Cancer via the Chest-Breast Approach
Published on: November 28, 2025
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
Stéphane Bardet1, Elodie Malville, Jean-Pierre Rame
1Department of Nuclear Medicine and Thyroid Unit, Centre François Baclesse, 3 Avenue Général Harris, BP 5026, F-14076 Caen Cedex 05, France. s.bardet@baclesse.fr
European Journal of Endocrinology
|March 26, 2008
Summary
Lymph-node dissection (LND) significantly impacts lymph-node recurrence (LNR) risk in papillary thyroid cancer patients with macroscopic lymph-node involvement. Optimal LND at primary surgery is crucial for reducing LNR risk in these patients.
Area of Science:
- Oncology
- Surgical Oncology
- Endocrinology
Background:
- Papillary thyroid cancer (PTC) recurrence risk is influenced by lymph node status.
- The role of lymph-node dissection (LND) and the prognostic significance of lymph node involvement in PTC remain debated.
- Identifying factors predicting lymph-node recurrence (LNR) is critical for optimal patient management.
Purpose of the Study:
- To evaluate the influence of different LND procedures on LNR risk in PTC patients.
- To identify independent risk factors for LNR in PTC.
- To determine the prognostic impact of macroscopic versus microscopic lymph-node involvement.
Main Methods:
- Retrospective analysis of 545 PTC patients with primary tumors ≥10 mm and no distant metastases.
- Patients were categorized into three groups based on LND extent: no LND, bilateral central and lateral LND, or other LND modalities.
- 10-year cumulative LNR probability was assessed using multivariate analysis.
Main Results:
- Macroscopic lymph-node metastases, extra-thyroidal invasion, and male gender were independent LNR risk factors.
- Bilateral LND of central and lateral compartments demonstrated a protective effect against LNR (P=0.028).
- In patients with macroscopic lymph-node metastases, bilateral LND resulted in a significantly lower 10-year LNR probability compared to other LND groups (10% vs 30%, P<0.01).
Conclusions:
- Macroscopic lymph-node involvement, not microscopic, is a major determinant of LNR risk in PTC.
- Optimal lymph-node dissection during primary surgery is essential for patients with macroscopic lymph-node metastases.
- Prophylactic bilateral central and lateral LND may reduce LNR risk in selected PTC patients.

